Who owns VIGIL NEUROSCIENCE?
- Ticker: VIGL
- CUSIP Number: 92673k108
Tip: Access positions for across all investors
Analyze quarterly positions in Vigil Neuroscience with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Vigil Neuroscience stock
Who bought or sold VIGIL NEUROSCIENCE this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Atlas Venture Life Science Advisors | 5.8M | $23M | 0% | Jun 2024 |
|
Northpond Ventures | 4.2M | $14M | 0% | Sep 2024 |
|
Siren | 2.0M | $6.8M | 100% | Sep 2024 |
|
BVF | 1.8M | $6.2M | 0% | Sep 2024 |
|
Sphera Funds Management | 1.7M | $6.8M | -2% | Jun 2024 |
|
Point72 Asset Management | 1.6M | $5.4M | 8% | Sep 2024 |
|
Citadel Advisors | 1.4M | $4.9M | 0% | Sep 2024 |
|
683 Capital Management | 1.2M | $4.1M | 11% | Sep 2024 |
|
Vanguard Group | 815k | $3.3M | -9% | Jun 2024 |
|
Stempoint Capital | 744k | $2.5M | 0% | Sep 2024 |
|
Ensign Peak Advisors | 606k | $2.1M | 53% | Sep 2024 |
|
Deep Track Capital | 597k | $2.4M | -63% | Jun 2024 |
|
Pivotal bioVenture Partners Investment Advisor | 561k | $1.9M | 0% | Sep 2024 |
|
Rock Springs Capital Management | 472k | $1.9M | 0% | Jun 2024 |
|
OrbiMed Advisors | 449k | $1.5M | 0% | Sep 2024 |
|
BlackRock | 423k | $1.4M | 100% | Sep 2024 |
|
BlackRock | 405k | $1.6M | -54% | Jun 2024 |
|
Goldman Sachs Group | 401k | $1.6M | 2099% | Jun 2024 |
|
Arrowpoint Asset Management | 290k | $984k | 0% | Sep 2024 |
|
Standard Life Aberdeen | 235k | $799k | 100% | Sep 2024 |
|
Geode Capital Management | 226k | $769k | 42% | Sep 2024 |
|
Woodline Partners | 144k | $490k | -30% | Sep 2024 |
|
Marshall Wace | 144k | $490k | 100% | Sep 2024 |
|
Bridgeway Capital Management | 80k | $320k | 38% | Jun 2024 |
|
Northern Trust | 50k | $171k | -64% | Sep 2024 |
|
Citigroup | 48k | $165k | 1907% | Sep 2024 |
|
Renaissance Technologies | 46k | $156k | -36% | Sep 2024 |
|
Alpine Partners VI | 45k | $180k | 100% | Jun 2024 |
|
Barclays | 45k | $152k | 0% | Sep 2024 |
|
State Street Corporation | 41k | $163k | -86% | Jun 2024 |
|
Qube Research & Technologies | 30k | $122k | 100% | Jun 2024 |
|
Sherbrooke Park Advisers | 26k | $90k | 100% | Sep 2024 |
|
Bank of America Corporation | 24k | $80k | -12% | Sep 2024 |
|
American Century Companies | 20k | $68k | 100% | Sep 2024 |
|
Morgan Stanley | 20k | $79k | -15% | Jun 2024 |
|
Cubist Systematic Strategies | 16k | $54k | 331% | Sep 2024 |
|
Two Sigma Investments | 12k | $48k | -73% | Jun 2024 |
|
Tower Research Capital | 12k | $47k | 103% | Jun 2024 |
|
Point72 Asia | 12k | $40k | -47% | Sep 2024 |
|
Jump Financial | 10k | $34k | 100% | Sep 2024 |
|
Gotham Asset Management | 5.9k | $207k | 100% | Sep 2024 |
|
Russell Investments | 2.0k | $8.1k | 100% | Jun 2024 |
|
Macquarie Group | 831.00 | $3.3k | 100% | Jun 2024 |
|
Royal Bank of Canada | 471.00 | $2.0k | -98% | Sep 2024 |
|
Jpmorgan Chase & Co | 414.00 | $1.4k | -95% | Sep 2024 |
|
Federated Investors | 198.00 | $673.002000 | 0% | Sep 2024 |
|
NISA Investment Advisors | 45.00 | $153.000000 | -40% | Sep 2024 |
|
Point72 | 7.00 | $24.000200 | -100% | Sep 2024 |
|
Who sold out of Vigil Neuroscience?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Artal Group | Jun 2024 | 1.8M | $7.3M |
Millennium Management | Jun 2024 | 335k | $1.3M |
Jane Street | Jun 2024 | 62k | $249k |
Susquehanna International | Jun 2024 | 48k | $192k |
Y-Intercept | Jun 2024 | 38k | $154k |
Centiva Capital | Jun 2024 | 33k | $131k |
Nuveen Asset Management | Mar 2024 | 27k | $92k |
Two Sigma Advisers | Mar 2024 | 24k | $82k |
Sunrise Partners Limited Partnership | Jun 2024 | 17k | $66k |
Mirae Asset Global Etfs Holdings | Jun 2024 | 8.1k | $33k |
Acadian Asset Management | Jun 2024 | 6.6k | $26k |
Rhumbline Advisers | Jun 2024 | 2.6k | $10k |
New York State Common Retirement Fund | Jun 2024 | 140.00 | $1.0k |
CWM | Jun 2024 | 16.00 | $0 |